Skip to main content
Premium Trial:

Request an Annual Quote

Proteomics Market to Grow Six-Fold, Reach $5.6B by 2006, Frost & Sullivan Report Predicts

Premium

The global proteomics market is projected to grow nearly six-fold to $5.6 billion by 2006, according to market research conducted by Frost & Sullivan. In 2000, the total market was $963 million, the consultancy said.

In a report released in August, Frost & Sullivan said the discovery that the human genome contains fewer genes than originally predicted has elevated the potential importance of proteins and led to an interest in proteome-wide studies.

The report, which separates proteomics by tool providers and drug discovery companies, offers the most aggressive forecast to date for the sector.

In June, Front Line Strategic Management Consulting forecast that the proteomics market would increase from a $561-million market to a $2.8-billion market by 2005.

In its report, Front Line forecast that a few players would continue to control the mass spectrometry market and that the 2D gel market would shrink as faster, simpler tools were developed.

Front Line said that the protein chip market would also grow, naming Ciphergen Biosystems as a leader in the space. The report also singled out Integrative Proteomics for its efforts to speed up protein analysis. — Kirell Lakhman

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.